Plus Therapeutics Inc
XBER:XMPA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Plus Therapeutics Inc
XBER:XMPA
|
US |
|
A
|
American Financial Group Inc
F:QFI
|
US |
|
A
|
Applied Blockchain Inc
NASDAQ:APLD
|
US |
|
F3 Uranium Corp
F:GL7
|
CA |
|
Bumi Serpong Damai Tbk PT
OTC:BSPDY
|
ID |
|
S
|
Smiths Group PLC
OTC:SMGKF
|
UK |
|
R
|
Ryde Group Ltd
AMEX:RYDE
|
SG |
|
R
|
Renaissancere Holdings Ltd
XBER:RRJ
|
BM |
|
Spartan Delta Corp
F:4YJ0
|
CA |
|
S
|
Substrate Artificial Inteligence SA
MAD:SAI
|
ES |
|
TUI AG
OTC:TUIFF
|
DE |
|
DFS Furniture PLC
LSE:DFS
|
UK |
|
Y
|
Yancoal Australia Ltd
OTC:YACAF
|
AU |
|
R
|
Rupert Resources Ltd
OTC:RUPRF
|
CA |
|
J
|
Jaguar Mining Inc
F:32JP
|
CA |
|
Smartsheet Inc
NYSE:SMAR
|
US |
|
Go Fashion (India) Ltd
BSE:543401
|
IN |
|
CBL & Associates Properties Inc
LSE:0HQK
|
US |
|
S
|
Smartsheet Inc
XBER:3SE
|
US |
|
I
|
Ibiden Co Ltd
XMUN:IBI
|
JP |
|
B
|
Basler AG
XHAM:BSL
|
DE |
|
Ignitis Grupe AB
F:IGV0
|
LT |
|
Immobiliere Dassault SA
F:6KP
|
FR |
|
Highpeak Energy Inc
NASDAQ:HPK
|
US |
Bankruptcy Probability
Plus Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Plus Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Plus Therapeutics Inc
NASDAQ:PSTV
|
28.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
382.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
153.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Plus Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Plus Therapeutics Inc has total debt of 750k USD. This includes both short-term (750k USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
